江南化工(002226.SZ):江南化工擬向江陽爆破增資6534.72萬元
格隆匯10月16日丨江南化工(002226.SZ)公佈,公司於2023年10月16日召開第六屆董事會第二十三次會議審議通過了《關於向全資孫公司增資的議案》。為了發揮山西江陽工程爆破有限公司(簡稱“江陽爆破”)爆破工程和礦山施工總承包“雙一級”資質優勢,把江陽爆破打造成江南化工直接控股下的礦山施工總承包多區域的業務發展平台,同意江南化工以江陽爆破2022年12月末每股淨資產為基礎,以自有資金增資6534.7188萬元,其中4200萬元計入註冊資本,23,347,188.44元計入資本公積。本次增資完成後,江陽爆破註冊資本增加至人民幣6200萬元,江南化工成為江陽爆破控股股東,持股比例67.74%,北方爆破科技有限公司持股比例稀釋為32.26%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.